The epidemiological evidence for a relationship between diet and indicators of asthma and chronic obstructive pulmonary disease (COPD) is evaluated. The review focuses on the intake of Na, n-3 fatty acids, and antioxidant vitamins as well as fruit and vegetables. Experimental studies suggest that a high-Na diet has a small adverse effect on airway reactivity in asthma patients. However, observational studies provide no clear evidence that high Na intake has adverse effects on airway reactivity or asthma symptoms in open populations. n-3 Polyunsaturated fatty acids, which are present in fish oils, are metabolized into less broncho-constricting and inflammatory mediators than n-6 polyunsaturated fatty acids. Studies in the general adult population suggest that a high fish intake has a beneficial effect on lung function, but the relationship with respiratory symptoms and clinically-manifest asthma or COPD is less evident. Also, experimental studies in asthma patients have not demonstrated an improvement in asthma severity after supplementation with fish oil. Several studies showed a beneficial association between fruit and vegetable intake and lung function, but the relationship with respiratory symptoms and the clinically-manifest disease was less convincing. A similar pattern was found for vitamin C in relation to indicators of asthma and COPD, but there are still conflicting results with respect to vitamin E and β-carotene. In conclusion, the epidemiological evidence for a beneficial effect on indicators of asthma and COPD of eating fish, fruit and vegetables is increasing. However, the effectiveness of dietary supplementation in open-population samples is often not demonstrated. Several unresolved questions are raised, which should be addressed in future studies on the relationship between diet and respiratory disease.
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Over the last few decades, the morbidity and mortality of asthma and chronic obstructive pulmonary disease (COPD) have been rising worldwide. Increasingly, it is believed that this rise is associated with the development of a 'Western lifestyle', accompanied by unfavourable changes in exposure to air pollution, tobacco smoke, and housing conditions and respiratory infections in early life (von Mutius et al. 1994) . Diet is an important aspect of Western lifestyle. Changes in dietary habits, such as increasing salt intake, decreasing intake of fruits and vegetables, and changing fatty acid composition of the diet, were suggested to contribute to the rise in asthma and COPD mortality and morbidity (Burney, 1987; Chang et al. 1993; Seaton et al. 1994; Sridhar, 1995; Black & Sharpe, 1997) .
Sodium, potassium and magnesium Burney (1987) noted that geographical variations in asthma mortality across England and Wales were accompanied by similar regional differences in table salt consumption; high salt consumption was present in regions with high asthma mortality. He suggested that increasing dietary Na caused an increase in airway reactivity through potentiation of the electrogenic Na pump in the membrane of the airway smooth muscle.
The effect of changes in Na intake on airway reactivity and other respiratory end points has been investigated in human experimental studies. The first experimental study was performed in a small group of asthmatic patients and non-asthmatic subjects (Javaid et al. 1988) . This study showed an increased bronchial reactivity to histamine in asthmatics, after doubling the salt intake for 1 month. No change was observed in non-asthmatics. Further studies were restricted to asthmatic patients and showed consistent evidence that increased airway reactivity was associated with high-Na diets (Burney et al. 1989; Medici & Vetter, 1991; Carey et al. 1993) . The evidence of a relationship with other respiratory end points such as medication use and lung function variables was not consistent (Medici & Vetter, 1991; Lieberman & Heimer, 1992; Carey et al. 1993) . Carey et al. (1993) noted that the difference in airway reactivity between asthmatic subjects on a low-salt diet and on salt supplementation was relatively small. They suggested that 'sodium restriction as a therapeutic intervention may only be of use in asthmatic patients with high daily sodium intakes'.
From the public health point of view the question arising is whether Na intake has adverse respiratory effects in nonasthmatics. In addition to the study by Javaid et al. (1988) , which showed no effect in a small number of non-asthmatic patients, information may be derived from observational studies in open populations, as these populations consist mainly of non-asthmatics (Table 1) . Burney et al. (1986) observed a positive association between Na excretion and airway reactivity, but this was not confirmed in later studies among population samples (Sparrow et al. 1991; Pistelli et al. 1993; Britton et al. 1994a) . Possibly the positive association observed by Burney et al. (1986) was partly due to the over-representation of 'wheezers' in that study. The relationship between K excretion and airway reactivity was also inconsistent between these studies: Burney et al. (1986) observed no relationship, whereas Sparrow et al. (1991) and Pistelli et al. (1993) observed an increased airway reactivity in association with increasing K excretion in adult males and in boys respectively. In National Health and Nutrition Examination Survey (NHANES) II, a high Na:K value was associated with an increased risk of bronchitis, but not of wheeze (Schwartz & Weiss, 1990 ). This is not consistent with the proposed causal mechanism of increased airway reactivity. Pistelli et al. (1993) reported an increased risk of cough, phlegm and wheezing with increasing table salt use in boys only. The experimental study by Burney et al. (1989) had also shown that the adverse effect of Na was restricted to men. Some mechanistic explanations were suggested for these sex differences (Knox, 1993) . However, since most studies were restricted to men because of these earlier observations, the evidence in women is not sufficient to evaluate whether a differential effect exists between sexes.
Mg has been shown to have broncho-dilating properties in experimental studies, but little epidemiological information on a possible beneficial association between Mg intake and airway reactivity is available. One large cross-sectional study reported a beneficial association between Mg intake and respiratory end points such as lung function, wheezing and airway reactivity (Britton et al. 1994b) . These authors suggested that Mg intake may act as a confounder in the relationship between Na intake and airway reactivity in open populations, since refined and processed foods, characteristic of a Western lifestyle, are low in Mg and high in salt.
In conclusion, there is substantial evidence for an adverse effect of a high-Na diet on airway reactivity in asthma patients from experimental studies, although the effect was small. Observational studies provide no consistent evidence for an adverse effect of Na or K intake on airway reactivity or other asthma symptoms in open populations. Epidemiological evidence on the potential beneficial effect of Mg intake is not sufficient to draw firm conclusions.
Polyunsaturated fatty acids
Polyunsaturated fatty acids include n-6 and n-3 fatty acids. The n-6 fatty acids are more likely to stimulate the disease process in asthma and COPD, whereas n-3 fatty acids are thought to inhibit this process. Linoleic acid, an n-6 fatty acid which is present in animal fat, is metabolized to arachidonic acid, which generates potent inflammatory mediators and broncho-constricting agents. Consistent with this mechanism, Miedema et al. (1993) observed an increased risk of 25-year incidence of chronic non-specific lung disease with increasing intake of linoleic acid (relative risk 1·55; 95 % CI 1·11, 2·16). However, other studies have not confirmed this observation (Troisi et al. 1995; Hodge et al. 1996) .
n-3 Fatty acids are abundantly present in fish, in particular in fatty fish, and are metabolized to eicosapentaenoic acid (EPA) and docosahexaenoic acid. EPA and docosahexaenoic acid may competitively inhibit the use of arachidonic acid as a substrate for the production of proinflammatory mediators such as prostaglandins and leukotrienes (Holtzman, 1991; Simopoulos, 1991) . Mediators derived from EPA have diminished biological activity compared with the arachidonic acid-derived mediators. Several experimental studies, reviewed by Monteleone & Sherman (1997) , have shown that supplementation of a Western diet (which is rich in n-6 fatty acids) with EPA and docosahexaenoic acid from fish led to increased docosahexaenoic acid and EPA content in cell membranes. However, often no improvement in the clinical manifestation of asthma was observed (Arm et al. 1988; Kirsch et al. 1988) . No intervention studies have been published on the effect of fish oil supplementation in COPD patients or in symptom-free subjects.
Several observational studies (Table 2) showed no relationship between fish intake and respiratory symptoms or clinically-manifest respiratory disease as an outcome variable (Schwartz & Weiss, 1990; Miedema et al. 1993; Troisi et al. 1995; Fluge et al. 1998) . However, Shahar et al. (1994a) showed a strong beneficial association between fish intake and the prevalence of COPD. This association was restricted to former and current smokers. A beneficial association between oily-fish intake and asthma was also observed in children (Hodge et al. 1996) . NHANES I (Schwartz & Weiss, 1994b ) and the Honolulu Heart Program (Sharp et al. 1994) were consistent in showing that the forced expiratory volume in 1 s (FEV 1 ) was higher in subjects with high levels of fish intake. In NHANES I, the magnitude of the effect was slightly higher after exclusion of smokers (Schwartz & Weiss, 1994b) , whereas the relationship in the Honolulu Heart Program was only observed in smokers (Sharp et al. 1994) . Some other points need to be raised before drawing conclusions relating to the true protective effect of fish intake in the general population. Thien et al. (1996) questioned whether a true protective effect may be expected at usual levels of intake. He pointed out that the level of fish intake in the general population of about one portion per week is equivalent to 0·2-0·8 g EPA/week. This is much lower than doses of 2-3 g EPA and docosahexaenoic acid/d, at which beneficial effects were observed in experimental studies. Britton (1995) pointed out that modification of the effect due to smoking habits was not only inconsistent between studies, but was also inconsistent between subgroups within studies. Thien et al. (1996) and Britton (1995) both argued that confounding by other aspects of a healthy diet or a healthy lifestyle may explain at least part of the observed beneficial effect. However, the study by Hodge et al. (1996) showed that the relationship in children was independent of other dietary habits.
In summary, the findings of several large studies in adults suggest that high fish intake has beneficial effects on lung function. It is not clear, however, whether smokers have more or less benefit from high fish intake than non-smokers. The relationship between fish intake and respiratory symptoms and clinical disease is less evident.
Antioxidants
Vitamins C and E and β-carotene are antioxidant (pro)vitamins that may protect the lungs from oxidative damage resulting from smoking or air pollution (Heffner & Repine, 1989) . Vitamin C is a water-soluble vitamin mainly present in fruit and vegetables. It is an oxygenradical scavenger, present in both extracellular and intracellular fluids in the lungs. Furthermore, vitamin C is able to regenerate oxidized vitamin E. Vitamin E is present in vegetable oils and margarines and comprises four lipid-soluble tocopherols (α-, β-, δ-and γ-tocopherol). α-Tocopherol is the most active antioxidant of the four tocopherols. It is present in the lipid membranes and in the extracellular fluids, where it converts oxygen radicals and lipid peroxyl radicals to less-reactive forms. β-Carotene (provitamin A) is mostly present in vegetables. It is a lipid-soluble antioxidant (free-radical scavenger) present in tissue membranes.
Several experimental studies have evaluated whether antioxidant (pro)vitamins are able to modulate the acute harmful effects of oxidative air pollution on the lungs (Hackney et al. 1981; Chatham et al. 1987; Mohsenin, 1987 Mohsenin, , 1991 Bucca et al. 1992; Grievink et al. 1998a; Romieu et al. 1998) . These studies differed in many aspects, such as the experimental conditions (chamber or ambient air exposure), level and type of oxidative air pollution (O 3 , NO 2 , or a mixture of urban air pollution), dose and duration of antioxidant supplementation (vitamins C or E or β-carotene or combinations of these vitamins), as well as outcome measures (from lipid peroxidation and inflammation markers to lung function, airway reactivity and symptoms). Despite the methodological differences, the results of these studies provide relatively consistent evidence that antioxidant supplementation has the potential to protect against the acute damage of oxidative air pollution. In addition to these experimental studies, two intervention studies have evaluated the potential protective effect of antioxidant supplementation on chronic respiratory end points under normal living conditions. The AlphaTocopherol Beta-Carotene Cancer Prevention Study investigated the effect of supplementation with α-tocopherol (50 mg/d) and β-carotene (20 mg/d) for 6 years among 29 133 smokers on the 5-8-year incidence of COPD symptoms: the results showed no effect of this form of supplementation (Rautalahti et al. 1997) . The Beta-Carotene and Retinol Efficacy Trial investigated the effect of 11-year supplementation with β-carotene (30 mg/d) and vitamin A (7·5 mg/d) on lung function decline in 3056 subjects. The annual decline in lung function did not differ between the supplementation group and the placebo group (Balmes et al. 1998) . Thus, large-scale intervention studies so far have shown no protective effect of antioxidant supplementation on chronic respiratory end points.
Observational studies in the open population provide information on the association between antioxidant intake at true levels of intake. Table 3 summarizes the design of the published observational studies. CNSLD, chronic non-specific lung disease; NHANES, National Health and Nutrition Examination Survey; RR, relative risk; OR, odds ratio; FVC, forced vital capacity; FEV 1 , forced expiratory volume in 1 s; FFQ, food-frequency questionnaire; SFFQ, semi-quantitative food-frequency questionnaire. * Defined as episodes of symptoms or specialist's diagnosis of asthma or COPD. † Based on symptoms: (1) history of chronic productive cough, (2) doctor's diagnosed emphysema, (3) spirometrically-detected COPD (FEV 1 ≤ 65 % predicted value in the presence of a normal FVC ≥ 80 % predicted value). ‡ Presence of airway hyper-responsiveness (provocative dose resulting in 20 % decrease in FEV 1 after exercise) and recent wheeze (wheeze in the past 12 months with or without exercise). 
Fruits and vegetables
The relationship between fruit and vegetable intake and respiratory symptoms or disease incidence is equivocal (Table 4 ). The Zutphen study observed a protective effect of fruit intake on the 25-year incidence of chronic non-specific lung disease (Miedema et al. 1993) , but the Nurses' Health Study reported no relationship between total fruit intake and the 10-year incidence of asthma (Troisi et al. 1995) . One cross-sectional study in children observed no relationship between fruit intake and wheeze (Cook et al. 1997) . Another survey among adults demonstrated a beneficial association between vegetable consumption and chronic bronchitis or asthma (LaVecchia et al. 1998) . Findings with respect to fruit intake and lung function (FEV 1 and forced vital capacity) give a more consistent picture. In NHANES I, no relationship was observed between fruit intake and airway obstruction (Morabia et al. 1989) . Possibly the use of a dichotomous outcome resulted in a lack of power to detect a small effect. A beneficial association between fruit intake and lung function (in particular FEV 1 ) was observed in other cross-sectional surveys (Strachan et al. 1991; Cook et al. 1997; Carey et al. 1998) . The estimates of the effect were of the same order of magnitude: FEV 1 for subjects with 'high' fruit intake (once per week or more) was about 80-100 ml higher than that for subjects with a 'low' fruit intake (less than once per week). Since these results were observed in cross-sectional studies only, one may argue that the association between fruit intake and FEV 1 was caused by another underlying factor, such as aspects of a healthy diet other than fruit intake, or more generally, a healthy lifestyle. Strachan et al. (1991) included several indicators of a healthy lifestyle (e.g. levels of passive smoking, alcohol consumption, physical activity) in the analysis and observed no change in the relationship between fruit intake and FEV 1 . Although the effects of a healthy lifestyle cannot be completely accounted for in observational studies, these results suggest that factors associated with healthy lifestyle have no substantial impact on the relationship between fruit intake and lung function.
In conclusion, the relationship between fruit and vegetable intake and FEV 1 is more consistent than that with respiratory symptoms or respiratory morbidity. A possible explanation is that the observed changes in lung function are too small to result in clinically-manifest disease. Another explanation may be that the effects are reversible, and for that reason they do not result in clinically-manifest disease. The prospective study recently reported by Carey et al. (1998) sheds more light on the issue of reversibility. It was shown that a decreasing frequency of fresh fruit consumption over a period of 7 years was accompanied by a decrease in FEV 1 . However, the average level of fruit intake over the 7-year period was not associated with a change in FEV 1 . This suggests that the effect of fruit intake has a reversible effect on the lungs.
Vitamin C
Most studies observed no relationship between vitamin C and asthma or COPD symptoms (Table 5) . Exceptions were NHANES II, which demonstrated a beneficial association between bronchitis or wheeze and serum vitamin C in the absence of a relationship with the intake of vitamin C Troisi et al. (1995) Intake of fruit and fruit juice* No association with 10-year incidence of asthma Dow et al. (1996) Total fruit and vegetable intake* No association with FEV 1 and FVC Cook et al. (1997) Fresh fruit intake (summer + winter) Green salad (summer + winter) and green vegetables, never v. > once per d
Fruit: beneficial association with FEV 1 FEV 1 79 ml higher (95 % CI 22, 136) for high v. low intake Vegetables and salad: similar relationship but less pronounced Fruit and vegetables: no association with wheeze La Vecchia et al. (1997) Vegetable consumption, > once per d v. < once per d
Beneficial association with chronic bronchitis; high v. low vegetable intake OR 0·69 (95 % CI 0·61, 0·78) Beneficial association with bronchial asthma: high v. low vegetable intake OR 0·70 (95 % CI 0·61, 0·78) Carey et al. (1998) Fruit intake at HALS 1 and HALS 2 daily v. never Average fruit intake of HALS 1 and HALS 2 Change in fresh fruit intake over 7-years follow-up Cross-sectional: beneficial association with FEV 1 high v. low fruit intake HALS 1 105 ml higher FEV 1 , HALS 2 188 ml higher FEV 1 Average FEV 1 of two surveys not related to annual change in FEV 1 Beneficial association of change in FEV 1 with change in fruit intake Men and women with decrease in fruit consumption respectively lost 89 and 133 ml FEV 1 /year more than those with no change in fresh fruit consumption FEV 1 , forced expiratory volume in 1 s; FVC, forced vital capacity; OR, odds ratio; RR, relative risk; CNSLD, chronic non-specific lung disease; HALS, Health and Lifestyle Survey. * No quantitative information on cut-off points of high v. low.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0029665199000427 (Schwartz & Weiss, 1990) . In contrast to the hypothesis of a beneficial association, the Nurses' Health Study reported an increase in the 10-year incidence of asthma associated with increasing dietary vitamin C (Troisi et al. 1995) . As a possible explanation the authors suggested that women with recurrent respiratory problems may have been more likely to take vitamin C supplements. A beneficial association between vitamin C and lung function (in particular FEV 1 ) was observed repeatedly. The effect was of similar magnitude throughout the studies: a 100 mg increase in vitamin C intake/d was associated with about 10-50 ml increase in FEV 1 (Schwartz & Weiss, 1990; Britton et al. 1995; Grievink et al. 1998b) . Two studies observed no statistically significant relationship between vitamin C and airway obstruction (Morabia et al. 1989) or FEV 1 (Dow et al. 1996) , but the effect in the latter relatively small study was of similar magnitude. A beneficial association was observed between vitamin C intake and bronchial reactivity (Soutar et al. 1997 ) and between non-fasting plasma vitamin C and lung function (FEV 1 and forced vital capacity) in men (Ness et al. 1996) . In line with the hypothesis that antioxidants protect against oxidative damage, it would be expected that the protective effect would be larger in smokers than in non-smokers. However, none of the reported studies has demonstrated modification of the effect by smoking. Although the studies often had a large sample size, it is likely that after stratification for smoking habits, the sample size had become too small to detect a difference between effects in smokers and non-smokers, given that the effect is already small. In summary, there is substantial evidence for a beneficial effect of vitamin C on lung function (in particular FEV 1 ). The effect of vitamin C on development of asthma or COPD derived from prospective studies and the relationship between vitamin C and respiratory symptoms in crosssectional studies is less convincing.
Vitamin E
The evidence for a beneficial protective effect of vitamin E intake on symptoms of asthma or of COPD is still small (Table 6 ); a beneficial association was observed with the 10-year incidence of asthma in women (Troisi et al. 1995) and with the prevalence of COPD symptoms in men (Rautalahti Dow et al. (1996) Vitamin C intake: median 49 (range 49-228) mg/d
No association with FEV 1 and FVC FEV 1 0·7 ml higher and FVC 1 ml higher, with vitamin C intake higher by 1 mg/d (NS) Ness et al. (1996) Non-fasting plasma vitamin C: men 46 µmol/l, women 58 µmol/l
Men: beneficial association with FEV 1 and FVC; FEV 1 220 ml higher (95 % CI 0·10, 0·33) and FVC 230 ml higher (95 % CI 0·09, 0·37) per 50 µmol/l Women: no association Soutar et al. (1997) Vitamin et al. 1997). Troisi et al. (1995) suggested that recent intake was more important for the beneficial association with vitamin E than past intake, based on the observation in the Nurses' Health Study that baseline vitamin E intake was not associated with a beneficial effect, whereas the vitamin E intake re-assessed after 4 and 6 years was associated with a beneficial effect. A higher FEV 1 associated with higher vitamin E intake was reported by Britton et al. (1995) and Dow et al. (1996) , although the relationship in the latter study disappeared after adjustment for vitamin C. Other studies observed no associations between vitamin E and indicators of asthma or COPD. Thus, the evidence for a protective effect of vitamin E intake on respiratory symptoms and lung function is equivocal. Given the biological interaction between vitamin C and vitamin E, the extent to which the protective effect of vitamin E is related to vitamin C is unresolved.
b-Carotene
Most of the studies in Table 7 showed no relationship between β-carotene intake and respiratory symptoms (Soutar et al. 1997; Grievink et al. 1998b ), the 25-year incidence of chronic non-specific lung disease (Miedema et al. 1993) , or the 10-year incidence of asthma (Troisi et al. 1995) , although the beneficial association was of borderline significance in the latter study. Only the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study showed a beneficial association between (serum and dietary) β-carotene and COPD symptoms (Rautalahti et al. 1997) . FEV 1 and forced vital capacity were not associated with dietary β-carotene in the study among male asbestos workers (Chuwers et al. 1997) , but a beneficial association was observed with serum β-carotene in the same study and with dietary β-carotene in the MORGEN study (Grievink et al. 1998b) . As for vitamin E, it is concluded that the available evidence from observational studies is insufficient and too conflicting to draw conclusions as to a potential protective effect of β-carotene on asthma or on COPD. In addition to β-carotene, other carotenoids have antioxidant activity, such as α-carotene and lycopene. These carotenoids are not investigated separately in observational studies. The intake of total carotene was not associated with FEV 1 and forced vital capacity in a cross-sectional study (Shahar et al. 1994) or with the 10-year incidence of asthma (Troisi et al. 1995) . Although β-carotene is a provitamin A and has antioxidant properties, preformed vitamin A (retinol) has no antioxidant properties (McLaren et al. 1993) . Retinol is assumed to repair damage from inflammation to the lung epithelium cells. In NHANES I (Morabia et al. 1989 (Morabia et al. , 1990 ) a beneficial association was observed between retinol and airway obstruction and also the prevalence of dyspnoea, but not bronchitis (Rautalahi et al. 1997) . Using the same methodology as in NHANES I, the analysis of the Atherosclerosis Risk in Communities study (with a larger study sample) showed no relationship between total carotene or retinol and airway obstruction (Shahar et al. 1994) . In other studies, such as the Nurses' Health Study, the Zutphen study and NHANES II, no beneficial association was observed between vitamin A and the incidence of asthma, chronic non-specific lung disease or the prevalence of bronchitis and wheeze (Schwartz & Weiss, 1990; Miedema et al. 1993 ; Including supplements: no association with 10-year incidence of asthma, high v. low intake RR 0·83 (NS) Britton et al. (1995) Vitamin E intake: 6·2 (SD 2·2) mg/d
Beneficial association with FEV 1 and FVC FEV 1 20 ml higher (95 % CI 1·3, 40·4) and FVC 23 ml (95 % CI 1, 45) higher with vitamin E intake 2·2 mg/d (1 SD) higher after adjusting for vitamin C (NS) Dow et al. (1996) Vitamin E intake: median 5·3 (range 1·1-15·7) mg/d Troisi et al. 1995) . Thus, no firm conclusion on the relationship between vitamin A and asthma or COPD can be drawn from the available evidence.
Concluding remarks
There is increasing evidence from observational studies that diet is related to respiratory disease. For Na intake an unfavourable association is observed in asthmatics, but the intake of fruit and vegetables and fish is more likely to be beneficial. However, the effectiveness of dietary supplementation in open-population samples has not been demonstrated. A possible explanation is that beneficial effects of dietary supplementation may be restricted to subjects with respiratory symptoms or to patients with clinical diagnosis of asthma or COPD. After evaluation of the available studies, some aspects remain unresolved and deserve further investigation in future studies (for example, see Strachan et al. 1991; Britton, 1995; Carey et al. 1998): which disease entity is related to diet? End points in observational studies are often lung function variables or self-reported respiratory symptoms, which are not specific enough to distinguish between asthma and COPD. Bronchial reactivity as an end point already provides more information, but this method is applicable only to a limited extent in largescale studies. is a beneficial effect of diet persistent, or short term and reversible? is a healthy diet more likely to have a beneficial effect in children than in adults? are beneficial effects restricted to subgroups such as smokers only or patients only?
is a beneficial effect of fruit and vegetable intake due to the presence of antioxidants only, or do any other bioactive nutrients play a role?
The most important question, however, is whether the relationship between diet and respiratory disease is a causal one. Although the relationship cannot be easily explained by other lifestyle factors in observational studies, it cannot be excluded that other underlying factors related to a 'healthy diet' are responsible for potential beneficial effects of diet.
